New arm therapy hopes to help stroke survivors regain movement
NCT ID NCT07233161
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a therapy called m-CIMT for people who recently had a stroke and have weakness in one arm. The therapy involves restraining the good arm and doing specific exercises with the weak arm to improve its use. Researchers will measure changes in arm function, daily activities, and fatigue in 66 participants over the first 15 days after their stroke.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- m-CIMT (modified constraint-induced movement therapy) - a behavioral therapy involving restraint of the unaffected arm and exercises for the affected arm
- What this could lead to
- If successful, this therapy could help recent stroke survivors regain more use of their weakened arm, improving daily activities and quality of life.
- What could go wrong
- This is a small, early-stage trial with only 66 participants, so results may not apply to everyone. The therapy requires active participation and may not work for all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ISQUEMIC STROKE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hospital Clinic de Barcelona
RECRUITINGBarcelona, Barcelona, 08036, Spain